Search Results

There are 78030 results for: content related to: Warfarin Sodium

  1. Determination of free and total warfarin concentrations in plasma using UPLC MS/MS and its application to a patient samples

    Biomedical Chromatography

    Volume 26, Issue 1, January 2012, Pages: 6–11, Mahasen A. Radwan, Ghada A. Bawazeer, Nouf M. Aloudah, Bushra T. AlQuadeib and Hassan Y. Aboul-Enein

    Article first published online : 4 MAR 2011, DOI: 10.1002/bmc.1616

  2. Comparative pharmacokinetics of coumarin anticoagulants X: Relationship between distribution, elimination, and anticoagulant action of warfarin

    Journal of Pharmaceutical Sciences

    Volume 63, Issue 6, June 1974, Pages: 868–872, Avraham Yacobi, L. B. Wingard Jr. and Gerhard Levy

    Article first published online : 17 SEP 2006, DOI: 10.1002/jps.2600630613

  3. Poisoning with Warfarin and Superwarfarin: What Can Laboratory Testing Do?

    Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring: A Comprehensive Guide

    Amitava Dasgupta, Pages: 161–184, 2012

    Published Online : 9 JUL 2012, DOI: 10.1002/9781118347867.ch9

  4. Comparative pharmacokinetics of coumarin anticoagulants XXI: Effect of plasma protein binding on distribution kinetics of warfarin in rats

    Journal of Pharmaceutical Sciences

    Volume 66, Issue 4, April 1977, Pages: 567–572, Avraham Yacobi and Gerhard Levy

    Article first published online : 18 SEP 2006, DOI: 10.1002/jps.2600660428

  5. In vivo and in vitro availability of commercial warfarin tablets

    Journal of Pharmaceutical Sciences

    Volume 60, Issue 5, May 1971, Pages: 666–677, John G. Wagner, Peter G. Welling, Kwang P. Lee and Jonathan E. Walker

    Article first published online : 16 SEP 2006, DOI: 10.1002/jps.2600600503

  6. Case Study: Warfarin Pharmacogenetics from Single to Multiple Genes

    Cardiovascular Genetics and Genomics

    Michael D. Caldwell, Richard Berg, Pages: 231–247, 2009

    Published Online : 27 APR 2009, DOI: 10.1002/9781444311785.ch15

  7. Automated analysis of warfarin sodium tablets

    Journal of Pharmaceutical Sciences

    Volume 65, Issue 10, October 1976, Pages: 1522–1525, S. Hanna, G. Dzus, L. Rasero and L. Lachman

    Article first published online : 18 SEP 2006, DOI: 10.1002/jps.2600651026

  8. Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon

    British Journal of Clinical Pharmacology

    Volume 77, Issue 4, April 2014, Pages: 626–641, Talitha I. Verhoef, William K. Redekop, Ann K. Daly, Rianne M. F. van Schie, Anthonius de Boer and Anke-Hilse Maitland-van der Zee

    Article first published online : 20 MAR 2014, DOI: 10.1111/bcp.12220

  9. Comparative pharmacokinetics of coumarin anticoagulants XXIV: Effect of treatment with phenobarbital on serum protein binding of warfarin and dicumarol in rats

    Journal of Pharmaceutical Sciences

    Volume 66, Issue 7, July 1977, Pages: 941–943, Avraham Yacobi, John T. Slattery and Gerhard Levy

    Article first published online : 18 SEP 2006, DOI: 10.1002/jps.2600660709

  10. Effect of temperature on binding of warfarin by human serum albumin

    Journal of Pharmaceutical Sciences

    Volume 65, Issue 11, November 1976, Pages: 1673–1677, Y. T. Oester, Steven Keresztes-Nagy, Roland F. Mais, Jack Becktel and John F. Zaroslinski

    Article first published online : 17 SEP 2006, DOI: 10.1002/jps.2600651127

  11. Effects of phenylbutazone, tolbutamide, and clofibric acid on binding of racemic warfarin and its enantiomers to human serum albumin

    Journal of Pharmaceutical Sciences

    Volume 68, Issue 12, December 1979, Pages: 1515–1518, K. Veronich, G. White and A. Kapoor

    Article first published online : 22 SEP 2006, DOI: 10.1002/jps.2600681213

  12. GLC determination of warfarin in human plasma

    Journal of Pharmaceutical Sciences

    Volume 67, Issue 1, January 1978, Pages: 84–86, S. Hanna, M. Rosen, P. Eisenberger, L. Rasero and L. Lachman

    Article first published online : 21 SEP 2006, DOI: 10.1002/jps.2600670121

  13. You have full text access to this OnlineOpen article
    Duration of warfarin sodium therapy prior to electrical cardioversion of atrial fibrillation

    Journal of Internal Medicine

    Volume 253, Issue 1, January 2003, Pages: 76–80, J. Ryman, M. Frick, V. Frykman and M. Rosenqvist

    Article first published online : 10 JAN 2003, DOI: 10.1046/j.1365-2796.2003.01084.x

  14. You have full text access to this OnlineOpen article
    Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects

    British Journal of Clinical Pharmacology

    Volume 74, Issue 1, July 2012, Pages: 116–124, Rajesh Krishna, Daria Stypinski, Melissa Ali, Amit Garg, Josee Cote, Andrea Maes, Bruce DeGroot, Yang Liu, Susie Li, Sandra M. Connolly, John A. Wagner and S. Aubrey Stoch

    Article first published online : 11 JUN 2012, DOI: 10.1111/j.1365-2125.2012.04171.x

  15. Indication for Anticoagulation Post-Percutaneous Coronary Intervention

    Pharmacology in the Catheterization Laboratory

    Ron Waksman, Andrew E. Ajani, Pages: 250–256, 2009

    Published Online : 30 OCT 2009, DOI: 10.1002/9781444306347.ch33

  16. Effect of variation of plasma oleic acid concentration on relative concentration of free and protein bound warfarin

    Journal of Pharmaceutical Sciences

    Volume 70, Issue 1, January 1981, Pages: 114–115, Peter A. Schwartz, Douglas S. Greene and C. T. Rhodes

    Article first published online : 22 SEP 2006, DOI: 10.1002/jps.2600700133

  17. Comparative pharmacokinetics of coumarin anticoagulants V: Kinetics of warfarin elimination in the rat, dog, and rhesus monkey compared to man

    Journal of Pharmaceutical Sciences

    Volume 58, Issue 7, July 1969, Pages: 845–849, Renpei Nagashima and Gerhard Levy

    Article first published online : 17 SEP 2006, DOI: 10.1002/jps.2600580711

  18. Tecarfarin, a Novel Vitamin K Reductase Antagonist, Is Not Affected by CYP2C9 and CYP3A4 Inhibition Following Concomitant Administration of Fluconazole in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 51, Issue 4, April 2011, Pages: 561–574, Dr Linda M. Bavisotto, Dr David J. Ellis, Dr Peter G. Milner, Mr Daniel L. Combs, Mr Ian Irwin and Dr Daniel M. Canafax

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010370588

  19. No Increased Bleeding Events with Continuation of Oral Anticoagulation Therapy for Patients Undergoing Cardiac Device Procedure

    Pacing and Clinical Electrophysiology

    Volume 34, Issue 7, July 2011, Pages: 868–874, HUNG-KEI LI, FRANK C. CHEN, ROBERT F. REA, SAMUEL J. ASIRVATHAM, BRIAN D. POWELL, PAUL A. FRIEDMAN, WIN-KUANG SHEN, PETER A. BRADY, DAVID J. BRADLEY, HON-CHI LEE, DAVID O. HODGE, JOSHUA P. SLUSSER, DAVID L. HAYES and YONG-MEI CHA

    Article first published online : 16 MAR 2011, DOI: 10.1111/j.1540-8159.2011.03049.x

  20. Dissolution and ionization of warfarin

    Journal of Pharmaceutical Sciences

    Volume 73, Issue 7, July 1984, Pages: 946–948, V. J. Stella, K. G. Mooney and J. D. Pipkin

    Article first published online : 17 SEP 2006, DOI: 10.1002/jps.2600730721